These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
62 results:

  • 1. Highly sensitive and simultaneous detection of ctDNAs related to non-small cell lung cancer in serum using a catalytic hairpin assembly strategy in a SERS microfluidic chip.
    Cao X; Mao Y; Gu Y; Ge S; Lu W; Gu Y; Li Z
    J Mater Chem B; 2022 Aug; 10(32):6194-6206. PubMed ID: 35904034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
    Gauci ML; Aristei C; Becker JC; Blom A; Bataille V; Dreno B; Del Marmol V; Forsea AM; Fargnoli MC; Grob JJ; Gomes F; Hauschild A; Hoeller C; Harwood C; Kelleners-Smeets N; Kaufmann R; Lallas A; Malvehy J; Moreno-Ramirez D; Peris K; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; van Akkooi ACJ; Lorigan P; Garbe C; Lebbé C;
    Eur J Cancer; 2022 Aug; 171():203-231. PubMed ID: 35732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.
    Sun Y; Sun X; You C; Ma S; Luo Y; Peng S; Tang F; Tian X; Wang F; Huang Z; Yu H; Xiao Y; Wang X; Zhang J; Gong Y; Xie C
    Int J Biol Sci; 2021; 17(10):2523-2536. PubMed ID: 34326691
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic Mutation Analysis in small cell lung cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.
    Jin W; Lei Z; Xu S; Fachen Z; Yixiang Z; Shilei Z; Tao G; Zhe S; Fengzhou L; Su WH; Chundong G
    Biomed Res Int; 2021; 2021():3609028. PubMed ID: 33880365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. lung adenocarcinoma pathology stages related gene identification.
    Sun GZ; Zhao TW
    Math Biosci Eng; 2019 Oct; 17(1):737-746. PubMed ID: 31731374
    [No Abstract]    [Full Text] [Related]  

  • 7. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer.
    Li C; Ma X; Tan C; Fang H; Sun Y; Gai X
    Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
    Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
    Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
    Li HS; Lv RQ; Liu L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer.
    Zhou X; Xie W; Li Q; Zhang Y; Zhang J; Zhao X; Liu J; Huang G
    PLoS One; 2013; 8(12):e80576. PubMed ID: 24363807
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of EGFR, KRAS and p53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy.
    Yamaguchi F; Kugawa S; Tateno H; Kokubu F; Fukuchi K
    Lung Cancer; 2012 Dec; 78(3):201-6. PubMed ID: 23026641
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis.
    Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J
    Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
    Custodio AB; González-Larriba JL; Bobokova J; Calles A; Alvarez R; Cuadrado E; Manzano A; Díaz-Rubio E
    J Thorac Oncol; 2009 Jul; 4(7):891-910. PubMed ID: 19433989
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. K-RAS and p53 mutations in association with COX-2 and hTERT expression and clinico-pathological status of NSCLC patients.
    Strazisar M; Rott T; Glavac D
    Dis Markers; 2008; 25(2):97-106. PubMed ID: 18957720
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.
    Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2008 Mar; 9(2):78-84. PubMed ID: 18501093
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response.
    Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Kubo R; Iyoda A; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Farouk A; Fujisawa T
    Thorax; 2008 Jul; 63(7):642-7. PubMed ID: 18390633
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients.
    Chang YL; Wu CT; Lee YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):630-7. PubMed ID: 17723810
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.